YM Biosciences Inc has concluded a bought financing deal for gross proceeds of $23 million. The Mississauga ON-based firm will receive the financing from a syndicate led by Dundee Securities Corp and including Canaccord Capital Corp, Dlouhy Merchant Group and Haywood Securities. The proceeds will be used primarily to finance pivotal Phase III clinical trials for tesmilifene, a small molecule chemopotentiator for metastatic breast cancer and its le